Hope Of Low Priced Drugs Kindle As Gilead Teams Up With Indian Firms
This article was originally published in PharmAsia News
Executive Summary
Gilead’s much-hyped partnerships with Indian drug makers to sell cut price versions of its blockbuster hepatitis C treatment Sovaldi opens up a huge market opportunity.